Johnson & Johnson: Continue to believe in positive benefit-risk profile of COVID-19 vaccine
“We continue to believe in a positive benefit-risk profile of COVID-19 vaccine,” Johnson & Johnson said in response to the statement released after the US CDC Advisory Committee meeting.
more to come ....
Reprinted from FXStreet，the copyright all reserved by the original author.
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
Hot
No comment on record. Start new comment.